
BioNTech forms cancer immunotherapies partnership with UK Government
By 2030, the goal of the collaboration will be to provide 10,000 patients their own mRNA. A partnership between BioNTech and the UK government has been announced with the objective of hastening the development of individualized mRNA immunotherapies.